 |
Malvinder and Shivinder SinghHindu brothers, entrepreneurs and billionaires.
Country:
 India |
Content:
- Ranbaxy Heirs: A Billion-Dollar Pharmaceutical Empire
- Pharmaceutical and Healthcare Expertise
- Religare Enterprises: A Financial Powerhouse
- Educational Background and Professional Experience
- Risk-Taking and Success
- Commitment to Healthcare
- Conclusion
Ranbaxy Heirs: A Billion-Dollar Pharmaceutical Empire
Early Lives and Business InheritanceIndian brothers Malvinder and Shivinder Singh inherited a substantial stake (33.3%) in the renowned pharmaceutical company Ranbaxy Laboratories upon their father's untimely demise. Leveraging this legacy, they ventured into healthcare and finance, building a combined net worth of multiple billions, according to Forbes India's annual rankings.
Pharmaceutical and Healthcare Expertise
Malvinder spearheads Ranbaxy's pharmaceutical operations as President, while Shivinder oversees their healthcare interests, including a network of family-owned hospitals. Notably, they acquired one of India's largest cardiac institutes recently.
Religare Enterprises: A Financial Powerhouse
Beyond pharmaceuticals, the brothers established Religare Enterprises, a financial services firm operating in over 400 cities across India. Listed on the National Stock Exchange since 1994, Religare has a market capitalization of approximately $695 million.
Educational Background and Professional Experience
Malvinder, the elder brother, holds an economics degree and an MBA. He honed his banking skills at American Express in Delhi and Mumbai before joining Ranbaxy as a management trainee. Shivinder, the younger brother, earned a mathematics degree and an MBA in medicine. Despite his diverse educational background, he successfully navigated the healthcare industry.
Risk-Taking and Success
As the brothers often emphasize, "Great success usually comes at the heels of great risks." Their company has undertaken calculated risks that have paid off handsomely over time.
Commitment to Healthcare
Shivinder actively supports Fortis Healthcare and SRL Ranbaxy, demonstrating his unwavering commitment to the healthcare sector.
Conclusion
Malvinder and Shivinder Singh's business acumen and complementary skills have transformed their inherited wealth into a thriving multi-billion dollar enterprise. Their ventures in pharmaceuticals, healthcare, and finance have not only strengthened their family's legacy but also made a significant impact on the Indian economy.
